世界の髄膜炎菌感染症治療市場予測（～2024年）

• 英文タイトル：Global Meningococcal Infections Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR09D4126
• 出版社/出版日：GlobalInfoResearch / 2019年9月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、101ページ
• 納品方法：Eメール
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、髄膜炎菌感染症治療の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、グルココルチコイド、プロテインC濃縮物等、用途別セグメントは、病院、診療所、その他等に区分しました。髄膜炎菌感染症治療の世界市場概観、企業動向、企業別髄膜炎菌感染症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・髄膜炎菌感染症治療の市場概観
・髄膜炎菌感染症治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・髄膜炎菌感染症治療の企業別販売動向、市場シェア、市場集中度、競争動向
・髄膜炎菌感染症治療の世界市場規模
・髄膜炎菌感染症治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・髄膜炎菌感染症治療のアメリカ市場規模推移
・髄膜炎菌感染症治療のカナダ市場規模推移
・髄膜炎菌感染症治療のメキシコ市場規模推移
・髄膜炎菌感染症治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・髄膜炎菌感染症治療のドイツ市場規模推移
・髄膜炎菌感染症治療のイギリス市場規模推移
・髄膜炎菌感染症治療のロシア市場規模推移
・髄膜炎菌感染症治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・髄膜炎菌感染症治療の日本市場規模推移
・髄膜炎菌感染症治療の中国市場規模推移
・髄膜炎菌感染症治療の韓国市場規模推移
・髄膜炎菌感染症治療のインド市場規模推移
・髄膜炎菌感染症治療の東南アジア市場規模推移
・髄膜炎菌感染症治療の南米市場分析（ブラジル、アルゼンチン等）
・髄膜炎菌感染症治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・髄膜炎菌感染症治療の種類別分析/販売量、売上、市場シェア（抗生物質、グルココルチコイド、プロテインC濃縮物）
・髄膜炎菌感染症治療の用途別分析/市場規模（病院、診療所、その他）
・髄膜炎菌感染症治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・髄膜炎菌感染症治療の販売チャネル・代理店・貿易業者・ディーラー分析

Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality.

Scope of the Report:
The global Meningococcal Infections Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Meningococcal Infections Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Meningococcal Infections Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Meningococcal Infections Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Sanofi
GlaxoSmithKline
Novartis

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Antibiotics
Glucocorticoids
Protein C Concentrate

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

レポート目次

Table of Contents

1 Meningococcal Infections Treatment Market Overview
1.1 Product Overview and Scope of Meningococcal Infections Treatment
1.2 Classification of Meningococcal Infections Treatment by Types
1.2.1 Global Meningococcal Infections Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Meningococcal Infections Treatment Revenue Market Share by Types in 2018
1.2.3 Antibiotics
1.2.4 Glucocorticoids
1.2.5 Protein C Concentrate
1.3 Global Meningococcal Infections Treatment Market by Application
1.3.1 Global Meningococcal Infections Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Meningococcal Infections Treatment Market by Regions
1.4.1 Global Meningococcal Infections Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Meningococcal Infections Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Meningococcal Infections Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Meningococcal Infections Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Meningococcal Infections Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Meningococcal Infections Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Meningococcal Infections Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Meningococcal Infections Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Meningococcal Infections Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Meningococcal Infections Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Meningococcal Infections Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Meningococcal Infections Treatment Market Competition, by Players
3.1 Global Meningococcal Infections Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Meningococcal Infections Treatment Players Market Share
3.2.2 Top 10 Meningococcal Infections Treatment Players Market Share
3.3 Market Competition Trend
4 Global Meningococcal Infections Treatment Market Size by Regions
4.1 Global Meningococcal Infections Treatment Revenue and Market Share by Regions
4.2 North America Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
5 North America Meningococcal Infections Treatment Revenue by Countries
5.1 North America Meningococcal Infections Treatment Revenue by Countries (2014-2019)
5.2 USA Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
6 Europe Meningococcal Infections Treatment Revenue by Countries
6.1 Europe Meningococcal Infections Treatment Revenue by Countries (2014-2019)
6.2 Germany Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
6.4 France Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Meningococcal Infections Treatment Revenue by Countries
7.1 Asia-Pacific Meningococcal Infections Treatment Revenue by Countries (2014-2019)
7.2 China Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
7.5 India Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
8 South America Meningococcal Infections Treatment Revenue by Countries
8.1 South America Meningococcal Infections Treatment Revenue by Countries (2014-2019)
8.2 Brazil Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Meningococcal Infections Treatment by Countries
9.1 Middle East and Africa Meningococcal Infections Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
10 Global Meningococcal Infections Treatment Market Segment by Type
10.1 Global Meningococcal Infections Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Meningococcal Infections Treatment Market Forecast by Type (2019-2024)
10.3 Antibiotics Revenue Growth Rate (2014-2024)
10.4 Glucocorticoids Revenue Growth Rate (2014-2024)
10.5 Protein C Concentrate Revenue Growth Rate (2014-2024)
11 Global Meningococcal Infections Treatment Market Segment by Application
11.1 Global Meningococcal Infections Treatment Revenue Market Share by Application (2014-2019)
11.2 Meningococcal Infections Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Meningococcal Infections Treatment Market Size Forecast (2019-2024)
12.1 Global Meningococcal Infections Treatment Market Size Forecast (2019-2024)
12.2 Global Meningococcal Infections Treatment Market Forecast by Regions (2019-2024)
12.3 North America Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)
12.6 South America Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Meningococcal Infections Treatment Picture
Table Product Specifications of Meningococcal Infections Treatment
Table Global Meningococcal Infections Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Meningococcal Infections Treatment Revenue Market Share by Types in 2018
Figure Antibiotics Picture
Figure Glucocorticoids Picture
Figure Protein C Concentrate Picture
Table Global Meningococcal Infections Treatment Revenue (Million USD) by Application (2014-2024)
Figure Meningococcal Infections Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Meningococcal Infections Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Meningococcal Infections Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Meningococcal Infections Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Meningococcal Infections Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Meningococcal Infections Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Meningococcal Infections Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Meningococcal Infections Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Meningococcal Infections Treatment Type and Applications
Table Pfizer Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Meningococcal Infections Treatment Type and Applications
Table Sanofi Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Meningococcal Infections Treatment Type and Applications
Table GlaxoSmithKline Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Meningococcal Infections Treatment Type and Applications
Table Novartis Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Meningococcal Infections Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Meningococcal Infections Treatment Revenue Share by Players (2014-2019)
Figure Global Meningococcal Infections Treatment Revenue Share by Players in 2017
Figure Global Meningococcal Infections Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Meningococcal Infections Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Meningococcal Infections Treatment Revenue Market Share in 2018
Figure Global Meningococcal Infections Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Meningococcal Infections Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Meningococcal Infections Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Meningococcal Infections Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Meningococcal Infections Treatment Revenue Market Share by Regions in 2018
Figure North America Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure South America Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Table North America Meningococcal Infections Treatment Revenue by Countries (2014-2019)
Table North America Meningococcal Infections Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Meningococcal Infections Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Meningococcal Infections Treatment Revenue Market Share by Countries in 2018
Figure USA Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Table Europe Meningococcal Infections Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Meningococcal Infections Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Meningococcal Infections Treatment Revenue Market Share by Countries in 2018
Figure Germany Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure UK Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure France Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Meningococcal Infections Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Meningococcal Infections Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Meningococcal Infections Treatment Revenue Market Share by Countries in 2018
Figure China Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure India Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Table South America Meningococcal Infections Treatment Revenue by Countries (2014-2019)
Table South America Meningococcal Infections Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Meningococcal Infections Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Meningococcal Infections Treatment Revenue Market Share by Countries in 2018
Figure Brazil Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Meningococcal Infections Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Meningococcal Infections Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Meningococcal Infections Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Meningococcal Infections Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Meningococcal Infections Treatment Revenue and Growth Rate (2014-2019)
Table Global Meningococcal Infections Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Meningococcal Infections Treatment Revenue Share by Type (2014-2019)
Figure Global Meningococcal Infections Treatment Revenue Share by Type (2014-2019)
Figure Global Meningococcal Infections Treatment Revenue Share by Type in 2019
Table Global Meningococcal Infections Treatment Revenue Forecast by Type (2019-2024)
Figure Global Meningococcal Infections Treatment Market Share Forecast by Type (2019-2024)
Figure Global Antibiotics Revenue Growth Rate (2014-2019)
Figure Global Glucocorticoids Revenue Growth Rate (2014-2019)
Figure Global Protein C Concentrate Revenue Growth Rate (2014-2019)
Table Global Meningococcal Infections Treatment Revenue by Application (2014-2019)
Table Global Meningococcal Infections Treatment Revenue Share by Application (2014-2019)
Figure Global Meningococcal Infections Treatment Revenue Share by Application (2014-2019)
Figure Global Meningococcal Infections Treatment Revenue Share by Application in 2019
Table Global Meningococcal Infections Treatment Revenue Forecast by Application (2019-2024)
Figure Global Meningococcal Infections Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Meningococcal Infections Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Meningococcal Infections Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Meningococcal Infections Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)
Figure Europe Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)
Figure South America Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Meningococcal Infections Treatment Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介

世界の腱炎治療市場予測（～2024年）

Global Tendinitis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4320 2019年9月18日 124Pages
本調査レポートは、腱炎治療の世界市場について調べ、まとめました。種類別セグメントは、薬物療法、外科療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。腱炎治療の世界市場概観、企業動向、企業別腱炎治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米...

世界のアナフィラキシー治療市場予測（～2024年）

Global Anaphylaxis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3773 2019年9月18日 116Pages
本調査レポートは、アナフィラキシー治療の世界市場について調べ、まとめました。種類別セグメントは、経口、非経口、その他等、用途別セグメントは、食物アレルギー、花粉アレルギー、ホコリダニアレルギー、その他等に区分しました。アナフィラキシー治療の世界市場概観、企業動向、企業別アナフィラキシー治療シェア、市...

世界のダンピング症候群治療市場予測（～2024年）

Global Dumping Syndrome Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3928 2019年9月18日 124Pages
本調査レポートは、ダンピング症候群治療の世界市場について調べ、まとめました。種類別セグメントは、薬物療法、外科療法等、用途別セグメントは、病院、診療所、その他等に区分しました。ダンピング症候群治療の世界市場概観、企業動向、企業別ダンピング症候群治療シェア、市場規模推移、市場規模予測（2019年-20...

世界のバッテン病治療市場予測（～2024年）

Global Batten Disease Treatment Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
B-GIR09D0515 2019年9月4日 120Pages
本調査レポートは、バッテン病治療の世界市場について調べ、まとめました。種類別セグメントは、作業療法、理学療法等、用途別セグメントは、幼児NCL、後期幼児NCL、少年NCL、成人NCL等に区分しました。バッテン病治療の世界市場概観、メーカー動向、メーカー別バッテン病治療シェア、市場規模推移、市場規模予...

世界のレフサム病治療市場予測（～2024年）

Global Refsum Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4255 2019年9月18日 119Pages
本調査レポートは、レフサム病治療の世界市場について調べ、まとめました。種類別セグメントは、手術療法、薬物療法等、用途別セグメントは、病院、診療所、その他等に区分しました。レフサム病治療の世界市場概観、企業動向、企業別レフサム病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域...

世界のがん治療用遺伝子治療市場予測（～2024年）

Global Gene Therapies for Cancer Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3986 2019年9月18日 117Pages
本調査レポートは、がん治療用遺伝子治療の世界市場について調べ、まとめました。種類別セグメントは、遺伝子誘導免疫療法、腫瘍溶解性ウイルス療法、遺伝子導入等、用途別セグメントは、病院、クリニック、その他等に区分しました。がん治療用遺伝子治療の世界市場概観、企業動向、企業別がん治療用遺伝子治療シェア、市場...

世界の子宮肉腫治療市場予測（～2024年）

Global Uterine Sarcoma Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4349 2019年9月18日 122Pages
本調査レポートは、子宮肉腫治療の世界市場について調べ、まとめました。種類別セグメントは、手術、放射線療法、ホルモン療法等、用途別セグメントは、病院、診療所、その他等に区分しました。子宮肉腫治療の世界市場概観、企業動向、企業別子宮肉腫治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主...

世界の百日咳治療市場予測（～2024年）

Global Pertussis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4194 2019年9月18日 121Pages
本調査レポートは、百日咳治療の世界市場について調べ、まとめました。種類別セグメントは、アジスロマイシン、クラリスロマイシン、エリスロマイシン、その他等、用途別セグメントは、子供、大人等に区分しました。百日咳治療の世界市場概観、企業動向、企業別百日咳治療シェア、市場規模推移、市場規模予測（2019年-...

世界の緑内障治療市場予測（～2024年）

Global Glaucoma Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3994 2019年9月18日 118Pages
本調査レポートは、緑内障治療の世界市場について調べ、まとめました。種類別セグメントは、プロスタグランジンアナログ（PGA）、ベータブロッカー、アルファアゴニスト等、用途別セグメントは、クリニック、薬局、その他等に区分しました。緑内障治療の世界市場概観、企業動向、企業別緑内障治療シェア、市場規模推移、...

世界の咽頭後膿瘍治療市場予測（～2024年）

Global Retropharyngeal Abscess Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4264 2019年9月18日 124Pages
本調査レポートは、咽頭後膿瘍治療の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、鎮痛剤、外科ドレナージ、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。咽頭後膿瘍治療の世界市場概観、企業動向、企業別咽頭後膿瘍治療シェア、市場規模推移、市場規模予測（2019年-...

世界の咽頭後膿瘍治療市場予測（～2024年） A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess…
世界の腱炎治療市場予測（～2024年） Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons. Scope of the Report: The global Tendinitis Treatment market is valued at …
世界の小児慢性副鼻腔炎治療市場予測（～2024年） Pediatric chronic Rhinosinusitis is one of the major and common disorder among infants with significant morbidity. Its diagnosis involves sinus symptoms, with prolonged duration requiring standard medical therapy for more than 90 days. The main causative factors for pediatric chronic rhinosinusitis …
世界のアナフィラキシー治療市場予測（～2024年） Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death. It typically causes more than one of the following: an itchy rash, throat or tongue swelling, shortness of breath, vomiting, lightheadedness, and low blood pressure. These symptoms typically come on over minutes t…
世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…